These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 8477127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A, Ling EW, Levine M.
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
    Kildoo CW, Lin LM, Gabriel MH, Folli HL, Modanlou HD.
    Dev Pharmacol Ther; 1989 Aug; 14(2):77-83. PubMed ID: 2630235
    [Abstract] [Full Text] [Related]

  • 4. Vancomycin population pharmacokinetics in neonates.
    de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN.
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED, Herald M, Koura F.
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O, Al Omar S, Nazer LH, Mubarak S, Le J.
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The kinetic profile of vancomycin in neonates.
    Silva R, Reis E, Bispo MA, Almeida AM, Costa IM, Falcão F, Palminha JM, Falcão AC.
    J Pharm Pharmacol; 1998 Nov; 50(11):1255-60. PubMed ID: 9877311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ, Moore WS, Nichols K, Knoderer CA, Carella DM, Chopra A.
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of vancomycin in neonates.
    Seay RE, Brundage RC, Jensen PD, Schilling CG, Edgren BE.
    Clin Pharmacol Ther; 1994 Aug; 56(2):169-75. PubMed ID: 8062493
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.
    Pawlotsky F, Thomas A, Kergueris MF, Debillon T, Roze JC.
    Br J Clin Pharmacol; 1998 Aug; 46(2):163-7. PubMed ID: 9723826
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L, Elliott K, Mitchell-Van Steele A, Lomaestro B, Pai MP.
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.